Earlier this year, I managed the anesthesia of a 19-year-old male patient who suffered a malignant hyperthermic crisis more than 10 hours into a lengthy orthopedic procedure. My experience with MH was stressful but ended well, thanks to pre-emptive planning and proven treatment protocols that worked when it mattered most. The event impressed upon me the importance of having a fully stocked MH cart, a clearly written response protocol, and a surgical team trained in the recognition and management of MH. Be sure you can answer the following questions in order to avoid an MH emergency or avert disaster when the disorder strikes unexpectedly.
1. What are MH's risk factors? MH is inherited, so having close relatives with the disorder is probably the biggest risk factor. Patients with muscular dystrophy and myotonia may have adverse reactions to triggering medications — sevoflurane, desflurane, isoflurane, halothane, enflurane, methoxyflurane and succinylcholine — but these reactions are not considered to be true forms of MH. Susceptible patients can rather easily receive general anesthesia with non-triggering medications as long as the anesthesia provider knows to plan for the use of alternative agents, which include narcotics, nitrous oxide, propofol, ketamine, barbiturates, benzodiazepines and etomidate. Any local or regional anesthetics would also be safe for use on MH-susceptible patients.
2. How can you recognize early warning signs and symptoms? Patients experiencing an MH reaction will usually demonstrate a steadily increasing expired carbon dioxide level, tachycardia, muscle rigidity, and severe metabolic and respiratory acidosis. The rapid rise in body temperature often occurs later, manifesting as the syndrome's last symptom. As muscle breaks down, myoglobinuria may be evident on gross inspection of the urine.
The earliest sign of a metabolic disturbance in the case I worked was sinus tachycardia that increased steadily over about 10 minutes into the range of 160 beats per minute. The patient's end tidal carbon dioxide rose rapidly, reaching its peak around 80mmHg, despite a doubling of the minute ventilation. Peak airway pressures increased rapidly from 20cm to 45cm water, which may have resulted from chest wall rigidity or a reduced endotracheal tube diameter due to masseter spasm. The patient was in lateral position, facing away from the anesthesia team, making examination and evaluation more challenging. The only triggering agent to which he had been exposed was isoflurane. Fortuitously, a venous blood gas had been drawn 45 minutes earlier and was completely normal. In that short interval, a repeat venous blood gas showed that the patient's pH level had decreased to 7.0, his pCO2 was 98mmHg, his pO2 was 27mmHg and the lactic acid level had increased from 1 to 11. That is an impressive metabolic deterioration.
We decided to terminate the volatile anesthetic and begin the treatment protocol for MH, which began with a call to the Malignant Hyperthermia Association of the United States' hotline (800-MH-HYPER). Within moments, we spoke to an expert who provided invaluable suggestions and advice.
Follow This Step-By-Step Response Plan |
One of the most important factors in the adequate treatment of malignant hyperthermia is preparation. During residency training I was able to participate in an MH treatment simulation, and in the residency training I currently help direct, management of an MH crisis is a key scenario in our simulation curriculum. We teach residents to accomplish the following as quickly as possible: 1. Call for help. Treatment will be much easier with extra team members on hand. Tasks should be strategically divided to meet subsequent response goals. Expert assistance is also available 24 hours a day from the Malignant Hyperthermia Association of the United States' hotline (800-MH-HYPER). 2. Assign roles. Ask for assistance from all available healthcare professionals in the area who can accomplish the following simultaneously:
3. Plan aftercare
4. Follow-up
— Shawn Banks, MD |
3. What should an MH cart contain? MHAUS recommends that a response cart should contain a minimum of 36 vials of dantrolene, sterile water (non-bacteriostatic) in sufficient quantity to reconstitute those vials, sodium bicarbonate, furosemide, dextrose 50%, calcium chloride, regular insulin and lidocaine for injection. Supplies like 60ml syringes (for dantrolene), IV catheters, NG tubes and Toomey irrigation syringes should also be available. A full description of recommended MH cart contents can be found at www.mhaus.org.
4. What's the quickest way to prepare dantrolene sodium? This agent must be reconstituted from its dehydrated form with preservative-free sterile water. If a well-developed protocol and supplies have not been (continued on page 16) assembled in advance, you'll waste valuable time trying to locate the appropriate diluents.
During a crisis, recruit as many helpers as possible to reconstitute the dantrolene. Almost anyone can assist with this low-tech but time-consuming task; adult doses may require 8 to 9 vials, and may need to be repeated several times until symptoms abate. It may take 2 minutes or more for dantrolene to solubilize, so some experts advocate using warmed diluent to speed the preparation process. This may require storing the sterile water in a different location from the rest of the rescue supplies.
Understanding Malignant Hyperthermia |
Malignant hyperthermia is an inherited disorder of the skeletal muscle triggered by inhalational anesthetic agents or the muscle relaxant succinylcholine. It can result in hypermetabolism, skeletal muscle damage, hyperthermia and ultimately death if left untreated, according to Keith Metz, MD, JD, medical director of the Great Lakes Surgical Center in Southfield, Mich. Specific indications of MH include muscle rigidity and increased CO2 production (both early warning signs), muscle breakdown and marked temperature elevation (a late warning sign), says Dr. Metz, who adds that non-specific signs of MH include tachycardia, tachypnea, acidosis and hyperkalemia. He points out that the condition can occur at any time during anesthesia, while the patient is in the OR or PACU and even after treatment has been started. The Malignant Hyperthermia Association of the United States estimates the rate of occurrence between 1 in 5,000 and 1 in 65,000 administrations of general anesthesia with known triggering agents. According to MHAUS, MH-susceptible patients can be operated on safely as long as the anesthesia provider avoids the use of MH-triggering anesthetics (sevoflurane, desflurane, isoflurane, halothane, enflurane and methoxyflurane), understands and recognizes the warning signs and treatment of MH, continuously monitors the patient's exhaled carbon dioxide concentration and core temperature during surgery and recovery, and has an MH cart in the OR stocked with an adequate supply of dantrolene sodium. Anesthetics that are safe to use on MH-susceptible patients, according to MHAUS, include non-depolarizing muscle relaxants, local anesthetics, narcotics, nitrous oxide, propofol, ketamine barbiturates and etomidate benzodiazepines. Cheryl Fielder, RN, CASC, who successfully managed an MH event at the Peachtree Orthopaedic Surgery Center in Atlanta, Ga., says dantrolene is the only specific treatment for MH. She suggests you always have at least 36 vials of the drug on hand and create MH response kits that contain 1000cc sterile water, 2 60cc syringes, a 3-way stopcock, a mini-spike dispensing pen and a fluid path. When MH occurs, advises Ms. Fielder, send all available help to the bedside, discontinue triggering agents, hyperventilate the patient with 100% oxygen and begin a dantrolene 2.5mg/kg push, repeating as necessary to a total of 10mg/kg. MHAUS suggests you post an MH treatment plan and its emergency hotline number wherever general anesthesia is administered. In addition, the organization advises you to employ patient monitors that track end-tidal carbon dioxide, blood oxygen saturation and core body temperature. Finally, MHAUS recommends you have hypothermia blankets nearby and stock ice and refrigerated isotonic saline for IV infusion to actively cool the patient during an MH crisis. — Daniel Cook |